CTOs on the Move

Health Choice Network

www.hcnetwork.org

 
Health Choice Network (HCN) is a national model of a successful collaboration of community health centers (CHCs) and one of several HRSA-sponsored Health Center Controlled Networks. HCN is addressing health care disparities, providing health information technologies and strengthening the financial position of the community health care system. Founded in 1994 as a 501c(3) organization, HCN was created and is governed by its members who comprise a minority-based Board of Directors. Network members maintain their vital community orientation by retaining their local-governing, consumer-majority Boards of Directors. Community Health Centers that own and control the Network operate more efficiently, can deliver care ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Maylee Sanchez
 Chief Information Officer Profile

Similar Companies

Harrington Health

Harrington Health is a Wichita, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Campanile Plastic Surgery

Campanile Plastic Surgery is a Denver, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

mdINR

mdINR is a New Windsor, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Planned Parenthood of Orange and San Bernardino Counties

Planned Parenthood is the leading provider of reproductive health care in the country. At Planned Parenthood of Orange and San Bernardino Counties, we fight for the fundamental right of all individuals to determine their own destiny.

Fibrocell Science

Making an impact on rare and serious skin and connective tissue diseases Fibrocell Science is at the forefront of the exciting and promising field of personalized biologics. By extracting cells from skin to create localized therapies that are compatible with the unique biology of each patient, personalized biologics bring a transformational approach to drug development. It is Fibrocell’s scientific leadership and legacy in cultivating and harnessing autologous fibroblast cells that fuels its personalized biologics approach. Fibrocell’s proprietary technology uses a person’s own fibroblast cells – with or without genetic modification – to target localized treatment of rare and serious skin and connective tissue diseases.